011sek
4,4 %
Date:2025-05-14Time:17:29:42Latest report:Q1-2025List:Small CapTicker:ACTI
Market Cap:130 msekEnterprise Value:103 msekNet Sales:- msekEarnings:-39,8 msekEmployees:0ISIN:SE0001137985

Ratios

10-year key figure history for Active Biotech turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Active Biotech with index and moving average MA50 and MA200.

Stockprice:0,11
MA50:0,09
MA200:0,21
Price/MA200:-50,0 %
RSI (14):63,7
Price/MA50:22,6 %

Description

Active Biotech operates in the pharmaceutical industry and focuses on the development of innovative treatments for cancer and autoimmune diseases. The company researches new therapies that can improve patient outcomes and quality of life. The project portfolio includes both small, orally active immunomodulatory molecules and antibody-based immunotherapy. The company operates globally. Active Biotech was founded in 1998 and is headquartered in Lund.

Biotechnology